- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03363750
Study of Mind-Body Skills Groups for Adolescents With Depression in Primary Care
March 9, 2020 updated by: Michelle Salyers, Indiana University
Pilot Study of Mind-Body Skills Groups for Adolescents With Depression in Primary Care
The Center for Mind -Body Medicine has developed a mind-body skills group program that incorporates meditation, guided imagery, breathing techniques, autogenic training, biofeedback, genograms, and self-expression through words, drawings, and movement.
These mind-body skills are designed to increase self-awareness and self-regulation.
This program has been shown to significantly improve depression symptoms in children and adolescents with posttraumatic stress disorder in Gaza, but it has not yet been tested in a US adolescent population.
The purpose of this study is to determine the feasibility of using mind-body skills groups to reduce depression in adolescents and to investigate the effects of the program on factors such as self-efficacy, mindfulness and rumination which are likely to mediate improvement.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
49
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46254
- Eskenazi Health Primary Care
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 17 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Eskenazi Primary Care patients at time of screening
- 13-17 years old
- Diagnosis of depression confirmed by Mini International Neuropsychiatric Interview (MINI) Kid Screen (with adolescent)
- English speaking
- Willingness to attend mind body skills group for duration of the intervention (10 sessions over approximately 10 weeks)
Exclusion Criteria:
- History of bipolar disorder or psychosis
- Acute and immediate risk of suicide, determined by clinical assessment
- Lack of capacity to assent (adolescent) or lack of capacity to consent (parent/guardian)
- Previous participation by the adolescent in the Eskenazi Mind Body Group intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: mind-body-skills intervention
mind-body-skills group intervention offered weekly for 10 weeks
|
mind-body skills group program incorporates meditation, guided imagery, breathing techniques, autogenic training, biofeedback, genograms, and self-expression through words, drawings, and movement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Children's Depression Inventory-2 (CDI-2) scores
Time Frame: from baseline to within one month after end of intervention
|
self report long version (28 items) to assess the presence and severity of depressive symptoms in children
|
from baseline to within one month after end of intervention
|
|
Change in Children's Depression Inventory-2 (CDI-2) scores
Time Frame: from baseline to approximately 3 months after end of intervention
|
self report long version (28 items) to assess the presence and severity of depressive symptoms in children
|
from baseline to approximately 3 months after end of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Patient Health Questionnaire-9 (PHQ-9) score
Time Frame: from baseline to within one month after end of intervention
|
self report (9 questions) to screen for the presence and severity of depression
|
from baseline to within one month after end of intervention
|
|
Change in Patient Health Questionnaire-9 (PHQ-9) score
Time Frame: from baseline to approximately 3 months after end of intervention
|
self report (9 questions) to screen for the presence and severity of depression
|
from baseline to approximately 3 months after end of intervention
|
|
Change in Rumination Subscale of the Children's Response Style Questionnaire Score
Time Frame: from baseline to within one month after end of intervention
|
self report (13 questions) of rumination symptoms
|
from baseline to within one month after end of intervention
|
|
Change in Rumination Subscale of the Children's Response Style Questionnaire Score
Time Frame: from baseline to approximately 3 months after end of intervention
|
self report (13 questions) of rumination symptoms
|
from baseline to approximately 3 months after end of intervention
|
|
Change in Mindful Attention Awareness Scale-Adolescent (MAAS) score
Time Frame: from baseline to within one month after end of intervention
|
self report (14 questions) designed to assess open or receptive awareness of and attention to what is taking place in the present
|
from baseline to within one month after end of intervention
|
|
Change in Mindful Attention Awareness Scale-Adolescent (MAAS) score
Time Frame: from baseline to approximately 3 months after end of intervention
|
self report (14 questions) designed to assess open or receptive awareness of and attention to what is taking place in the present
|
from baseline to approximately 3 months after end of intervention
|
|
Change in Self-Efficacy Questionnaire for Depression in Adolescents (SEQ-DA) score
Time Frame: from baseline to within one month after end of intervention
|
self report (12 items) designed to measure self-perceived ability to cope with depressive symptoms
|
from baseline to within one month after end of intervention
|
|
Change in Self-Efficacy Questionnaire for Depression in Adolescents (SEQ-DA) score
Time Frame: from baseline to approximately 3 months after end of intervention
|
self report (12 items) designed to measure self-perceived ability to cope with depressive symptoms
|
from baseline to approximately 3 months after end of intervention
|
|
Change in Suicide Ideation Questionnaire (SIQ) score
Time Frame: from baseline to within one month after end of intervention
|
self report (30 or 15 items depending on grade level) to assess frequency of suicidal ideation
|
from baseline to within one month after end of intervention
|
|
Change in Suicide Ideation Questionnaire (SIQ) score
Time Frame: from baseline to approximately 3 months after end of intervention
|
self report (30 or 15 items depending on grade level) to assess frequency of suicidal ideation
|
from baseline to approximately 3 months after end of intervention
|
|
Acceptability Questionnaire
Time Frame: within one month after end of intervention
|
self report (15 items) intervention acceptability assessment of usefulness and helpfulness of the intervention
|
within one month after end of intervention
|
|
Acceptability Questionnaire
Time Frame: approximately 3 months after end of intervention
|
self report (15 items) intervention acceptability assessment of usefulness and helpfulness of the intervention
|
approximately 3 months after end of intervention
|
|
Acceptability Questionnaire - open-ended questions for qualitative analyses
Time Frame: within one month after end of intervention
|
3 open-ended questions to gather qualitative data about the usefulness and helpfulness of the intervention
|
within one month after end of intervention
|
|
Acceptability Questionnaire - open-ended questions for qualitative analyses
Time Frame: approximately 3 months after end of intervention
|
3 open-ended questions to gather qualitative data about the usefulness and helpfulness of the intervention
|
approximately 3 months after end of intervention
|
|
Change in Hope Scale Score
Time Frame: from baseline to within one month after end of intervention
|
|
from baseline to within one month after end of intervention
|
|
Change in Hope Scale Score
Time Frame: from baseline to approximately 3 months after end of intervention
|
|
from baseline to approximately 3 months after end of intervention
|
|
Change in Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) Score
Time Frame: from baseline to within one month after end of intervention
|
|
from baseline to within one month after end of intervention
|
|
Change in Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) Score
Time Frame: from baseline to approximately 3 months after end of intervention
|
|
from baseline to approximately 3 months after end of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michelle P Salyers, PhD, Indiana University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 25, 2018
Primary Completion (ACTUAL)
September 4, 2019
Study Completion (ACTUAL)
September 4, 2019
Study Registration Dates
First Submitted
November 21, 2017
First Submitted That Met QC Criteria
December 4, 2017
First Posted (ACTUAL)
December 6, 2017
Study Record Updates
Last Update Posted (ACTUAL)
March 10, 2020
Last Update Submitted That Met QC Criteria
March 9, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1707293729
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
Sheba Medical CenterNot yet recruiting
-
ACADIA Pharmaceuticals Inc.RecruitingACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response (NORLIGHT)Depressive Disorder, Treatment-Resistant | Major Depressive Disorder (MDD)United States
-
Rotman Research Institute at BaycrestRecruitingMajor Depressive Disorder (MDD)Canada
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingDepression - Major Depressive Disorder | Depression Chronic | Treatment-Resistant Major Depressive Disorder | Depression DisorderSpain
-
Second Affiliated Hospital of Tsinghua UniversityNot yet recruiting
-
First People's Hospital of HangzhouNot yet recruitingMajor Depressive Disorder
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
Shandong Provincial HospitalShandong UniversityRecruiting
-
Engrail Therapeutics INCCompletedMajor Depressive DisorderUnited Kingdom
Clinical Trials on mind-body-skills group
-
The Center for Mind-Body MedicineThe Atlantic PhilanthropiesCompletedPosttraumatic Stress DisorderIsrael
-
The Center for Mind-Body MedicineThe Atlantic PhilanthropiesCompletedPosttraumatic Stress DisorderIsrael
-
Weill Medical College of Cornell UniversityRecruitingDepressive Symptoms | Mood Change | Anxiety GeneralizedUnited States
-
The Center for Mind-Body MedicineSilicon Valley Community FoundationCompleted
-
Youngstown State UniversityCompleted
-
The Center for Mind-Body MedicineHerbert Simon Family FoundationCompleted
-
The Center for Mind-Body MedicineCompletedAggression | Problem Behavior | Posttraumatic Stress DisorderPalestinian Territory, occupied
-
The Center for Mind-Body MedicineCompletedStress Disorders, Post-traumaticFormer Yugoslavia
-
The Center for Mind-Body MedicineThe Atlantic PhilanthropiesCompletedPosttraumatic Stress DisorderIsrael
-
The Center for Mind-Body MedicineAmericaresRecruitingPost Traumatic Stress Disorder PTSDPalestinian Territories